Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
The Science of the Total Environment|August 14, 2021
Drug pollution & Sustainable Development GoalsS Domingo-Echaburu, L M Dávalos, G Orive, et al.
The Science of the Total Environment|January 10, 2022
Hazardous drugs (NIOSH's list-group 1) in healthcare settings: Also a hazard for the environment?S Domingo-Echaburu, A Lopez de Torre-Querejazu, Y Valcárcel, et al.
The Science of the Total Environment|February 23, 2023
Analyzing the potential environmental impact of NIOSH list of hazardous drugs (group 2)Z Abajo, A Jimenez, S Domingo-Echaburu, et al.
The Science of the Total Environment|January 22, 2022
Drugs used during the COVID-19 first wave in Vitoria-Gasteiz (Spain) and their presence in the environmentS Domingo-Echaburu, M Irazola, A Prieto, et al.
The Science of the Total Environment|January 23, 2021
Antipsychotics as environmental pollutants: An underrated threat?J Escudero, J L Muñoz, T Morera-Herreras, et al.
European Journal of Clinical Pharmacology|June 11, 2017
Hiccups in Parkinson's disease: an analysis of cases reported in the European pharmacovigilance database and a review of the literatureU Lertxundi, A C Marquínez, S Domingo-Echaburu, et al.
The Science of the Total Environment|February 23, 2023
Comprehensive micropollutant characterization of wastewater during Covid-19 crisis in 2020: Suspect screening and environmental risk prioritization strategyN Lopez-Herguedas, M Irazola, I Alvarez-Mora, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|October 8, 2008
Finite element analysis of the influence of the offset placement of an implant-supported prosthesis on bone stress distributionE Anitua, G Orive
Medicina Oral, Patologia Oral Y Cirugia Bucal|November 22, 2023
Medication impact on oral health in schizophreniaL Urien, N Jauregizar, U Lertxundi, et al.
Journal of Clinical Pharmacy and Therapeutics|May 19, 2016
Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance databaseM García, M A Aranburu, I Palacios-Zabalza, et al.
Pageof 7